Acadia Pharmaceuticals Inc
General
Total Cases10
Active Cases3
Patents90
Ratings
Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 02/19/25 | Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (nms) (Entered: 02/19/2025) | |
| 02/18/25 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by ACADIA Pharmaceuticals Inc. (jfm) (Entered: 02/18/2025) | |
| 02/18/25 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,601,740; 7,659,285; 7,732,615; 10,517,860; 10,953,000. (jfm) (Entered: 02/18/2025) | |
| 02/18/25 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 01/03/2025. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 7/3/2027. (jfm) (Entered: 02/18/2025) | |
| 02/18/25 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) (Entered: 02/18/2025) | |
| 02/18/25 | No Summons Issued. (jfm) (Entered: 02/18/2025) | |
| 02/18/25 | COMPLAINT against Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC (Filing fee $ 405, receipt number ADEDC-4615434) - filed by ACADIA Pharmaceuticals Inc. (Attachments: # [1] Exhibits A-E, # [2] Civil Cover Sheet)(jfm) (Entered: 02/18/2025) | |
| 02/13/25 | CORRECTING ENTRY: Deleted D.I. 133 at the request of counsel as the attachment is filed publicly at D.I. 134. (lnb) (Entered: 02/13/2025) | |
| 02/12/25 | POST TRIAL BRIEF by ACADIA Pharmaceuticals Inc.. (Attachments: # [1] Proposed Finding of Facts)(Streifthau-Livizos, Michelle) (Entered: 02/12/2025) | |
| 02/12/25 | [SEALED] Proposed Findings of Fact by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Myer, R.) (Entered: 02/12/2025) |